News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Soloway Thomas P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Soloway Thomas P (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $27.25, valued at
$545k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 06/08/2023 |
4
| Soloway Thomas P (Director) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Granted 16,250 options to buy
@ $5.03, valued at
$81.7k
|
|
| 03/08/2023 |
4
| Soloway Thomas P (Director) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Disposed/sold 76,582 options to buy
@ $8.61, valued at
$659.4k
Granted 76,582 options to buy
@ $4.2, valued at
$321.6k
Disposed/sold 13,667 options to buy
@ $17.83, valued at
$243.7k
Granted 13,667 options to buy
@ $4.2, valued at
$57.4k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Soloway Thomas P (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.6, valued at
$92k
|
|
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Unknown transaction of 183,384 shares
@ $60, valued at
$11M
Disposed/sold 3,829 options to buy
@ $2.7649, valued at
$10.6k
Disposed/sold 6,263 options to buy
@ $9.4988, valued at
$59.5k
Disposed/sold 73,781 options to buy
@ $15.26, valued at
$1.1M
Disposed/sold 75,000 options to buy
@ $27.39, valued at
$2.1M
Disposed/sold 65,000 options to buy
@ $24.74, valued at
$1.6M
|
|
| 01/10/2020 |
4
| Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Exercised 144,669 options to buy
@ $2.7649, valued at
$400k
Exercised 6,219 options to buy
@ $15.26, valued at
$94.9k
|
|
| 12/16/2019 |
4
| Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 8,681 shares
@ $59.37, valued at
$515.4k
Paid exercise price by delivering 21,458 shares
@ $59.37, valued at
$1.3M
Exercised 41,321 options to buy
@ $2.7649, valued at
$114.2k
|
|
| 12/09/2019 |
4
| Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 505 shares
@ $59.21, valued at
$29.9k
|
|
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,009 shares
@ $37.31, valued at
$37.6k
|
|
| 02/08/2019 |
4
| Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 23,333 shares
@ $0
Granted 65,000 options to buy
@ $24.74, valued at
$1.6M
|
|
| 11/17/2017 |
4
| Soloway Thomas P (Senior Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $27.39, valued at
$2.1M
|
|
| 01/27/2017 |
4
| Soloway Thomas P (Senior Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc. |
| 07/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/08/2013 |
4
| Soloway Thomas P (EVP, COO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 140,000 options to buy
@ $5.4, valued at
$756k
|
|
| 02/02/2012 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 60,000 options to buy
@ $8.09, valued at
$485.4k
|
|
| 12/05/2011 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Sold 25,150 shares
@ $8.2325, valued at
$207k
Sold 37,520 shares
@ $8.5671, valued at
$321.4k
Exercised 25,150 options to buy
@ $2.68, valued at
$67.4k
Exercised 37,520 options to buy
@ $0.8844, valued at
$33.2k
|
|
| 11/28/2011 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Sold 13,600 shares
@ $7.865, valued at
$107k
Exercised 13,600 options to buy
@ $2.68, valued at
$36.4k
|
|
| 08/25/2011 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 77,500 options to buy
@ $2.68, valued at
$207.7k
|
|
| 02/03/2011 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc|
Txns:
| Granted 58,000 options to buy
@ $8.2, valued at
$475.6k
|
|
| 01/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2009 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc |
| 02/03/2009 |
4
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc |
|
|